Cite
HARVARD Citation
Huerga, H. et al. (2022). Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line Drugs . Clinical infectious diseases. pp. 1307-1314. [Online].